Overview of HEOR
Join our community on Telegram!
Join the biggest community of Pharma students and professionals.
HEOR stands for Health Economics and Outcomes Research. It is a multidisciplinary field that assesses the value of healthcare interventions in terms of their cost-effectiveness, clinical outcomes, and impact on patient's quality of life. The main goal of HEOR is to provide evidence-based information to support healthcare decision-making, resource allocation, and policy development.
Here's a detailed overview of HEOR:
1. Introduction to HEOR: Health Economics and Outcomes Research is a branch of health economics that focuses on evaluating the clinical, economic, and humanistic outcomes of medical treatments, technologies, and healthcare interventions. It combines elements of health economics, epidemiology, biostatistics, health services research, and patient-reported outcomes to analyze the value and impact of healthcare interventions.
2. Key Components of HEOR:
- Economic Evaluation: This aspect involves conducting cost-effectiveness analyses, cost-benefit analyses, and cost-utility analyses to compare the costs of different interventions with their health outcomes. The aim is to determine which interventions provide the most value for money.
- Clinical Outcomes Assessment: This involves measuring the effectiveness of healthcare interventions in real-world settings. Clinical outcomes can include measures like reduction in mortality rates, improvement in disease-specific symptoms, and overall health status.
- Patient-Reported Outcomes (PROs): These are measures that capture the patient's perspective on their own health and treatment. PROs include quality of life assessments, patient satisfaction, and functional status questionnaires. Incorporating PROs helps in understanding the impact of treatments beyond clinical outcomes.
- Health Technology Assessment (HTA): HTA is a systematic evaluation of the properties, effects, and impacts of health technologies. It aims to inform healthcare policy and decision-making by assessing the clinical and economic value of technologies such as drugs, medical devices, and procedures.
